William Hahn
Executive Vice President and Chief Operating and Transformation Officer · Mass General Brigham
Credentials: · · ·
History
- Present
- 1997–1999
Center
- 1990–1994
Research
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
Nature · 2009 · 3,074 citations
Next-generation characterization of the Cancer Cell Line Encyclopedia
Nature · 2019 · 2,578 citations
Defining a Cancer Dependency Map
Cell · 2017 · Last of 25 authors · Corresponding · 2,574 citations
40 papers
- LG
39 papers
32 papers · 1 as a resident
28 papers
26 papers
20 papers
20 papers
18 papers
Grants
- 2026–2031
Context-Specific Pathway Dependencies for Nuclear Envelope Proteins in Brain Cancer
National Cancer Institute · R01
Contact PI · $718.3K · Dana-Farber Cancer Inst
- 2024–2029
Investigating CREB5-Driven Mechanisms of Immune Therapy Resistance
National Cancer Institute · R01
PI · $1.2M · Massachusetts General Hospital
- 2022–2027
Stromal Modulation of Pancreatic Cancer Malignant Cell State and Therapeutic Sensitivity
National Cancer Institute · U01
Contact PI · $5.1M · Dana-Farber Cancer Inst
- 2022–2026
Development of p300/CBP Histone Acetyltransferase Inhibitors for Oncogene-Driven Cancers
National Cancer Institute · R01
Contact PI · $2.6M · Broad Institute, Inc.